Quantcast
Last updated on April 16, 2014 at 17:34 EDT
Climbing Mount Everest To Learn More About Type 2 Diabetes

Climbing Mount Everest To Learn More About Type 2 Diabetes

April Flowers for redOrbit.com - Your Universe Online Most people engage in extreme sports, such as climbing Mount Everest, in an attempt to gain insight about themselves. A group of researchers from the University of Southampton and University...

Latest Diabetes Stories

2014-04-16 16:30:05

CHARLOTTE, N.C., April 16, 2014 /PRNewswire/ -- High manufacturer pricing for most branded diabetic testing products and the recent reduction in insurance reimbursement rates have coupled to reduce retailer and provider margins. To provide retailers serving the more than 25 million Americans with diabetes with a new solution, UniStrip Technologies introduces its first generic blood glucose test strip for use in LifeScan's® OneTouch® Ultra family of meters. Developed and tested...

2014-04-16 16:29:20

Despite progress continued efforts needed to combat diabetes complications ATLANTA, April 16, 2014 /PRNewswire-USNewswire/ -- Rates of five major diabetes-related complications have declined substantially in the last 20 years among U.S. adults with diabetes, according to a study by the Centers for Disease Control and Prevention, published in the current issue of the New England Journal of Medicine. Rates of lower-limb amputation, end-stage kidney failure, heart attack, stroke, and...

2014-04-15 23:15:08

National network of attorneys continues to offer no-cost consultations to consumers over allegations that Lipitor and other statins increase the risk of developing diabetes. San Diego, CA (PRWEB) April 15, 2014 http://www.resource4thepeople.com/defectivedrugs/lipitor-lawsuit.html Resource4thePeople today announced today the scheduling of a key court hearing involving litigation* containing allegations that the anti-cholesterol medication Lipitor may cause patients to develop diabetes....

2014-04-15 23:12:19

Avail is conducting a 6-week, Phase 2 randomized study to assess the safety, tolerability and pharmacodynamics of a new combination therapy administered to participants with type 2 diabetes mellitus. DeLand, FL (PRWEB) April 15, 2014 *To see if you qualify for this Diabetes Clinical Trial in DeLand, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us directly at (386) 785-2404. There is no cost to participate, no insurance required, and you may receive...

2014-04-15 23:09:00

The cancer information website Cancer Monthly says bladder cancer patients who took Actos should not wait to seek legal advice, despite drug maker’s plans to appeal a federal jury’s ruling. Raleigh, NC (PRWEB) April 15, 2014 The makers of the diabetes drug Actos say they will appeal last week’s award of $9 billion in punitive damages to a man who claims that Actos caused his bladder cancer, (1) (Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc., et al, No....

2014-04-15 23:08:18

Market Size - $20.97 bn in 2013, Market Growth - CAGR of 12.4%, Market Trends – Growing penetration of insulin products in Asian markets. View complete report - http://www.grandviewresearch.com/industry-analysis/insulin-market. San Francisco, California (PRWEB) April 15, 2014 The global market for insulin is expected to reach USD 47.54 billion by 2020, according to a new study by Grand View Research, Inc. Growing global prevalence of type I and type II diabetes and the presence of high...

2014-04-15 16:28:05

SARATOGA, Calif., April 15, 2014 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration, today announced two changes to its Board of Directors. Ophthalmic industry veteran, Mark Forchette has joined the board in a new seat; John Ryan is filling ONSET Ventures existing board seat. Mark Forchette brings thirty years of experience in ophthalmic sales, marketing and business unit...

2014-04-15 16:27:56

LONDON, April 15, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Tanzeum(TM) (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Albiglutide, a glucagon-like peptide-1 receptor agonist (GLP-1), is a biological product for the...

2014-04-14 23:08:39

Health News Wires reviews the top five ways to lower insulin resistance and what to consider when evaluating the health benefits of the best insulin resistance supplement. Boston, MA (PRWEB) April 14, 2014 A new article and video from Healthnewswires.com details signs of insulin resistance, benefits of an insulin resistant diet, and important considerations when looking for the best supplement to lower insulin resistance. Insulin resistance is a condition where the body fails to recognize...

2014-04-14 12:34:39

Organization to share tips from partnership with Lilly Diabetes to help people avoid disruptions in medical care during severe weather emergencies ORLANDO, Fla., April 14, 2014 /PRNewswire/ -- News Highlights: -- @TheAACE attends Hurricane Conference to share planning tips for people w/ #diabetes; prgm w/Lilly Diabetes offering emergency tips since '05 -- @TheAACE, in partnership with Lilly Diabetes, offers emergency planning tips for people with #diabetes at...


Latest Diabetes Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (3 articles) »